Krystal Biotech buy Chardan Capital
Start price
12.12.24
/
50%
€165.85
Target price
12.12.25
€201.99
Performance (%)
-25.47%
Price
19.08.25
€123.60
Summary
This prediction is currently active. The price of Krystal Biotech has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.47%. This prediction currently runs until 12.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.447% | 0.447% |
| iShares Core DAX® | 0.855% | 0.498% |
| iShares Nasdaq 100 | -1.591% | 1.232% |
| iShares Nikkei 225® | 0.299% | 9.734% |
| iShares S&P 500 | -0.197% | 1.747% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€125.75
25.07.25
25.07.25
€186.52
25.07.26
25.07.26
-1.71%
19.08.25
19.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-28.24%
19.08.25
19.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-18.63%
19.08.25
19.08.25